Spotlight on: Myomo, StartHub’s Startup to Watch for May

30MayMay 30, 2017

Spotlight on: Myomo, StartHub’s Startup to Watch for May

Portfolio News Myomo

Each month as part of StartHub Startups to Watch Program we connect with the winning company to learn more about them. The May Startup to Watch is Myomo, a Cambridge-based medical robotics company. Read more >>

01MayMay 1, 2017

Myomo pioneering an IPO that includes small investors

You might consider it a “people’s IPO.” If the medical robotics company Myomo Inc. goes public this month, as planned, it... read more

12NovNovember 12, 2019

Corbus Pharmaceuticals Updates Data from Lenabasum Open-Label Extension Studies in Systemic Sclerosis and Dermatomyositis at 2019 ACR Annual Meeting

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced continued... read more

28JulJuly 28, 2020

The Top 100 Executives Of 2020

With the worldwide COVID-19 pandemic and social unrest wreaking havoc on the global economy, this year proved that never has... read more

22NovNovember 22, 2016

Medical Robotics Firm Myomo Explores Going Public

Myomo, Inc., a commercial-stage medical robotics company whose products enable users to overcome upper extremity paralysis (www.myomo.com), announced today that... read more

08NovNovember 8, 2023

Wasabi Technologies Partners with Leading Security Providers to Deliver Next-Generation Cloud Storage to Australia and New Zealand Surveillance Industry

Wasabi Technologies, the hot cloud storage company, today announced partnerships with leading security providers in Australia and New Zealand, Channel... read more

08NovNovember 8, 2017

Staff Sgt. Robert Davis: Seeing is believing

Earlier this year Ms. Davis learned of the new technology entitled eSight’s glasses after a staff doctor demonstrated their use... read more

04OctOctober 4, 2017

Siamab Therapeutics Presents New Data at AACR’s Ovarian Cancer Conference Demonstrating its Anti-STn Antibody Therapeutics Inhibit Tumor Growth in Ovarian Cancer Models

Siamab Therapeutics, Inc., a biopharmaceutical company developing novel cancer immunotherapies, today announced the presentation of new preclinical data for its... read more

16NovNovember 16, 2018

Spotlight on: Myomo, StartHub’s Startup to Watch for May

Spotlight on: Myomo, StartHub’s Startup to Watch for May

Share this post

Related Posts